Advertisement

GI & Endoscopy

Sebela Pharmaceuticals and CellMax Life have entered a strategic development and commercial collaboration partnership to accelerate the development of CellMax's multimodal liquid biopsy blood test. 

Gastroenterology-focused software companies Iterative Scopes and Provation reached a partnership March 17 to link Provation's gastroenterology documentation software with Iterative Scopes' inflammatory bowel disease data and artificial intelligence insights. 

After more than two decades of helping freestanding, single-specialty endoscopic ASCs thrive across the U.S., Physicians Endoscopy is entering the next phase of growth and development. The company, which has partnerships with 60 gastroenterology surgery centers and more than 600…

Motus GI is on track to grow its Pure-Vu endoscopy system in 2021, according to CEO Tim Moran. He spoke on four value-creation drivers — reimbursement, product innovation, clinical data and strategic partnerships — in an earnings call transcribed by…

Advertisement

From studies on colorectal cancer risk factors to research on outpatient colonoscopies, here are nine recent studies catching the eyes of gastroenterologists:

Motus GI shared its fourth-quarter and full-year 2020 financial results, posting a $19.3 million net loss for the year, or a $0.60 loss per diluted share.

Advertisement